INDICATION: BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
IMPORTANT SAFETY INFORMATION: Contraindication: BRIUMVI is contraindicated in patients with:
- Active HBV infection
- A history of life-threatening infusion reaction to BRIUMVI
